Revasol Tussin DM Max with Honey

Manufacturer
Rnv LLC
Effective date
2025-03-21
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 00:57:35

Label at a glance#

ProductRevasol Tussin DM Max with Honey
Active ingredientGUAIFENESIN, DEXTROMETHORPHAN HYDROBROMIDE
Label structure13 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active ingredients (in each dose, 20 mL) Purpose

Dextromethorphan HBr 20 mg..........................Cough Suppressant

Guaifenesin 400 mg..........................................Expectorant

OTC - PURPOSE SECTION

Cough Suppressant

Expectorant

INDICATIONS & USAGE SECTION

Uses

• temporarily relieves cough as may occur with the common cold • helps
loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial
passageways of bothersome mucus.

WARNINGS SECTION

Warnings

Do not use • if you are now taking a prescription monoamine oxidase inhibitor
(MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or
Parkinson’s disease), or for 2 wekks after stopping the MAOI drug. If you do not
know if your prescription drug contains an MAOI, ask a doctor or pharmacist before
taking this product.

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have

• a cough that is accompanied by excessive
phlegm (mucus) • a persistent or chronic cough such as occurs wiht smoking,
asthma, chronic bronchitis, or emphysema

OTC - STOP USE SECTION

Stop use and ask a doctor if

• cough persists for more than 1 week, tends to
recur, or is accompanied by a fever, rash, or persistent headache. A persistent
cough may be a sign of a serious condition.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of the reach of children. In case of accidental overdose, get medical
help or contact a Poison Control Center right away.

DOSAGE & ADMINISTRATION SECTION

Directions
• do not exceed more than 6 doses in any 24-hour period
• shake well before use
• measure only with dosing cup provided
• keep dosing cup with product
• mL=mililiter • TSP=teaspoonful
• this adult product is not intended for use in children

AgeDose
adults and children 12 years of
age and over
20 mL
every 4 hours
children under 12 years of agedo not use

OTHER SAFETY INFORMATION

Other information
• each 20 mL contains: sodium 12 mg
• store at room temperature 15-30°C (59-86°F). Do not refrigerate

TAMPER-EVIDENT FEATURE: Do not use if printed safety seal is torn, broken or missing.

INACTIVE INGREDIENT SECTION

Inactive ingredients

citric acid, FD&C Yellow #6, flavors, glycerin, honey,
purified water, propylene glycol, sodium benzoate, sorbitol solution, sucralose.

OTC - QUESTIONS SECTION

Questions or comments 1-888-446-4753
Monday - Friday (9 AM - 5 PM EST)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

REVASOL DM MAX HONEY.JPGREVASOL DM MAX HONEY.JPG

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
2692303dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 20 mL Oral SuspensionPSN1
2692303dextromethorphan hydrobromide 1 MG/ML / guaifenesin 20 MG/ML Oral SuspensionSCD1
2692303dextromethorphan HBr 20 MG / guaifenesin 400 MG per 20 ML Oral SuspensionSY1
2692303dextromethorphan HBr 5 MG / guaifenesin 100 MG per 5 ML Oral SuspensionSY1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
DEXTROMETHORPHAN Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813
GUAIFENESIN Pharmacologic Class Indexing1Indexing - Pharmacologic Class20211129

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
bf324df6-7127-7deb-def5-2681c136cd03Product name320250325
43a1ed49-eae2-4840-8075-cb4b33478540Product name120230425
e2db08c6-133f-4f4f-afb4-e90a2418d6f6Product name120230320
ce6d5c06-3ae0-18a6-d5b3-8cd3cc0f8906Product name720210625
ba088a92-ab5e-b2d4-e908-f5ea691b7587Product name720210201
f52be47f-7aa7-46c0-b1fa-50c18dd50206Product name120201029
11ed6f83-cdd2-4637-8379-b1a1d3ae3cdeProduct name120181101
86c45a79-b9f0-4476-a27c-6e10db098497Product name120180125
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
4fe95224-f543-4dbb-9445-8cca122b48c8Product name120150609
e8718272-64cb-4436-969b-176c3067c8f4Product name120150609
106ff02a-57e1-4c4c-a307-fd582ff4e311Product name120150212
76633df9-0d59-4b88-03ed-21dee1b966f8Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
84379-274-04Revasol Tussin DM Max with Honey118 mL in 1 BOTTLELIQUID1181

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
84379-274REVASOL TUSSIN DM MAX WITH HONEY (DEXTROMETHORPHAN HBR AND GUAIFENESIN) LIQUID [RNV LLC]1Current NDC, 1 package rows20250323_30da9255-c93a-84d6-e063-6394a90a7c2a.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 16 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84379-27484379-274-04

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 12 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Revasol Tussin DM Max with HoneyDEXTROMETHORPHAN HBR AND GUAIFENESINRnv LLC30da9255-c93a-84d6-e063-6394a90a7c2a2025-03-21WarningsExact identifier
ndc (package): 84379-274-04
ndc (product): 84379-274
ndc11 (package): 84379027404
spl id: 30da9255-c93b-84d6-e063-6394a90a7c2a
spl set id: 30da9255-c93a-84d6-e063-6394a90a7c2a

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.